| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 02/09/2021 | VACINA CONTRA A SARS-COV2 - 02 DOSES | Butantan/CoronaVac | 290 | 0 | 0 | 0 | 0 | 290 |
| 02/09/2021 | VACINA CONTRA A SARS-COV2 - 10 DOSES | Butantan/CoronaVac | 290 | 0 | 0 | 0 | 0 | 290 |
| 05/09/2021 | VACINA CONTRA A SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 96 | 0 | 0 | 0 | 96 |
| 05/09/2021 | VACINA CONTRA A SARS-COV2 - 10 DOSES | Butantan/CoronaVac | 100 | 100 | 0 | 0 | 0 | 200 |
| 08/09/2021 | VACINA CONTRA A SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 84 | 0 | 0 | 0 | 84 |
| 08/09/2021 | VACINA CONTRA A SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 60 | 78 | 0 | 0 | 0 | 138 |
| 10/09/2021 | VACINA CONTRA A SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 66 | 0 | 0 | 0 | 0 | 66 |
| 10/09/2021 | VACINA CONTRA A SARS-COV2 - 10 DOSES | Butantan/CoronaVac | 60 | 60 | 0 | 0 | 0 | 120 |
| 10/09/2021 | VACINA CONTRA A SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 66 | 0 | 0 | 0 | 0 | 66 |
| 10/09/2021 | VACINA CONTRA A SARS-COV2 - 10 DOSES | Butantan/CoronaVac | 60 | 60 | 0 | 0 | 0 | 120 |
| 17/09/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | Fiocruz/Oxford/AstraZeneca | 0 | 82 | 0 | 3 | 0 | 85 |
| 17/09/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 150 | 48 | 0 | 6 | 0 | 204 |
| 18/09/2021 | VACINA CONTRA SARS-COV-2 - 10 DOSES | Butantan/CoronaVac | 141 | 150 | 9 | 0 | 0 | 300 |
| 08/10/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 136 | 0 | 2 | 0 | 138 |
| 13/10/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 167 | 0 | 1 | 0 | 168 |
| 20/10/2021 | VACINA CONTRA SARS-COV-2 - 10 DOSES | Butantan/CoronaVac | 0 | 180 | 0 | 0 | 0 | 180 |
| 22/10/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 239 | 0 | 1 | 0 | 0 | 240 |
| 22/10/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 132 | 0 | 6 | 0 | 138 |
| 23/10/2021 | VACINA CONTRA SARS-COV-2 - 05 DOSES | Fiocruz/Oxford/AstraZeneca | 0 | 189 | 0 | 1 | 0 | 190 |
| 26/10/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 286 | 0 | 2 | 0 | 288 |
| 26/10/2021 | VACINA CONTRA SARS-COV-2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 222 |
| 20/11/2021 | VACINA CONTRA SARS-COV2-06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 558 | 0 | 0 | 0 | 0 | 558 |
| 25/11/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 182 | 0 | 0 | 0 | 182 |
| 02/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 24 | 102 | 0 | 0 | 0 | 264 |
| 10/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 24 | 120 | 0 | 0 | 0 | 258 |
| 10/12/2021 | VACINA CONTRA SARS-COV2 - 05 DOSES | Fiocruz/Oxford/AstraZeneca | 20 | 0 | 0 | 0 | 0 | 20 |
| 10/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 15 |
| 16/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 65 |
| 16/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 100 | 0 | 0 | 0 | 204 |
| 16/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 204 |
